abacavir / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 48 Diseases   9 Trials   9 Trials   1108 News 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
abacavir / Generic mfg.
2011-004935-30: Study “before-after”: Adherence Evaluation to antiretroviral therapy administered in two different ways Studio ''before-after'' di valutazione dell'aderenza di due diverse modalita' di somministrazione della terapia antiretrovirale

Ongoing
4
400
Europe
Film-coated tablet, EPIVIR*FL 30CPR RIV 300MG, VIREAD*30CPR 245MG, ZIAGEN*6BLISTER 10CPR 300MG, SUSTIVA*30CPR RIV 600MG BLIST, RETROVIR*60CPR 300MG, TRUVADA*30CPR RIV 200MG/245MG, KIVEXA*BL 30CPR RIV 600MG+300M, COMBIVIR*60CPR RIV 150MG+300MG, ATRIPLA*30CPR RIV600+200+245MG
U.L.S.S. 9 DI TREVISO, studio no profit, farmaci a carico del SSN
HIV infection Infezione da HIV, HIV infection Infezione da HIV, Diseases [C] - Virus Diseases [C02]
 
 
2006-006174-19: A randomised, open label, phase IV comparative study to determine the effects on renal function of continuing treatment with tenofovir versus replacement with abacavir in HIV positive persons

Ongoing
4
30
Europe
Ziagen, Viread, Truvada, Kivexa, Not appllicable, Not applicable, Not appilcable, Ziagen, Viread, Truvada, Kivexa, Ziagen, Viread, Truvada, Kivexa
St Stephens AIDS Trust
HIV
 
 
2008-001472-69: Concentraciones intracelulares de Ribavirina trifosfato en pacientes coinfectados por el VHC/VIH. Influencia de Abacavir en la fosforilización intracelular de Ribavirina.

Ongoing
4
12
Europe
Ziagen, copegus (ribavirina), Ziagen, copegus (ribavirina)
Luis F. Lopez-Cortes
Hepatitis crónica y/o cirrosis hepática por virus CInfección por el VIH
 
 
ChiCTR1900027656: Analysis of the efficacy and safety of dotiapramib in the treatment of HIV infection

Recruiting
4
200
 
Dotiapramib tablets (contains 600 mg of abacavir sulfate, 300 mg of lamivudine and 50 mg of dotilavir sodium)
Chongqing Public Health Medical Treatment Center; Chongqing Public Health Medical Treatment Center, raise independently
AIDS
 
 
AVERTAS-1, NCT04904406: Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals

Completed
4
81
Europe
Dolutegravir / Lamivudine Oral Tablet, Dolutegravir/abacavir/lamivudine
Thomas Benfield
Hiv, HIV Infections, HIV Cardiomyopathy, Weight Change, Body, HIV Lipodystrophy, Cardiovascular Diseases
12/23
12/23
2006-004476-12: A randomised open-label study comparing the safety and efficacy of three different combination antiretroviral regimens as initial therapy for HIV infection.

Ongoing
3/4
80
Europe
Truvada, Efavirenz, Ritonavir, Atazanavir sulfate, Abacavir sulfate, Zidovudine, Truvada, Efavirenz, Ritonavir, Atazanavir sulfate, Abacavir sulfate, Zidovudine, Truvada, Efavirenz, Ritonavir, Atazanavir sulfate, Abacavir sulfate, Zidovudine
University of New South Wales
Chronic HIV infection
 
 
2015-005045-31: Switching to tenofovir alafenamide fumarate or abacavir in patients with renal impairment due to tenofovir disoproxil fumarate. Overgaan naar tenofovir alafenamide fumaraat of abacavir bij patienten met een nierfunctieverslechtering door tenofovir disoproxil fumaraat.

Ongoing
3
80
Europe
FTC/TAF 200mg/10mg, FTC/TAF 200mg/25mg, Film-coated tablet, Tablet, Descovy, Kivexa
Erasmus MC, Gilead Sciences Inc
Renal safety of switching from TDF to TAF or ABC in patients with TDF-associated eGFR-decline. renale veiligheid van switchen van TDF naar TAF of ABC bij patienten met een TDF-geassocieerde eGFR-daling., Therapy of HIV Behandeling van HIV, Diseases [C] - Virus Diseases [C02]
 
 
2016-002413-22: Open label, Randomized clinical trial to evaluate switching from dual regimens to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in virologically suppressed, HIV-1 infected patients Studio in aperto, randomizzato, per valutare il passaggio da una terapia duplice ad una terapia con E/C/F/TAF in pazienti adulti HIV positivi con carica virale negativa.

Ongoing
3
100
Europe
Tivicay (dolutegravir), Emtriva, Lamivudina, Viread, Ziagen, Edurant, Intelence, Sustiva, Viramune, Film-coated tablet, Capsule, hard, Tablet, Prolonged-release tablet, Genvoya¿ 150 mg/150mg/200mg/10mg, TIVICAY - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) - 30 COMPRESSE, EMTRIVA - 30 CAPSULE RIGIDE IN BLISTER DA 200 MG, LAMIVUDINA MYLAN - 300 MG COMPRESSE RIVESTITE CON FILM 30 COMPRESSE IN BLISTER PVC/PVDC/AL, VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE, ZIAGEN - 300 MG COMPRESSE FILMRIVESTITE 6 BLISTER 10 COMPRESSE USO ORALE, EDURANT - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) 30 COMPRESSE, INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE, SUSTIVA - 600 MG COMPRESSE FILM RIVESTITE 1 FLACONE 30 COMPRESSE USO ORALE, VIRAMUNE - 400 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - BLISTER (PVC/AL) 30 COMPRESSE
OSPEDALE SAN RAFFAELE, Gilead Sciences Inc.
HIV infection Infezione da HIV, HIV infected subjects pazienti affetti da virus HIV, Diseases [C] - Virus Diseases [C02]
 
 
PENCIL, NCT06356740: Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus

Not yet recruiting
2
70
Europe
Blood sample, Treatment :Abacavir 600 mg/lamivudine 300 mg, Lupus Impact Tracker questionnaire
Hospices Civils de Lyon
Systemic Lupus Erythematosus
11/28
06/29
NCT00537966: Characterization of Acute and Recent HIV-1 Infections in Zurich.

Recruiting
N/A
800
Europe
Dolutegravir, Tivicay, Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate, Genvoya, Raltegravir, isentress, Darunavir, Prezista, Ritonavir, Norvir, Rilpivirine, Edurant, Lamivudine, 3TC, tenofovir, Viread, Emtricitabine, Emtriva, Abacavir, Ziagen
University of Zurich
HIV Infections
12/28
12/28
ACTRN12607000030471: Identification of Susceptibility to Abacavir Hypersensitivity Reaction (HSR) in HIV-1 Infected Patients in Sydney, Australia and Development of Mechanisms for Risk Reduction

Not yet recruiting
N/A
500
 
Holdsworth House Medical Practice, GlaxoSmithKline Australia
Human Immunodeficiency Virus Type-1 (HIV-1)
 
 

Download Options